Pharma

Your Article Summary

See Latest Articles

Adolor Corporation Announces Staff Reductions and Restructuring
Adolor Corporation, 06/04/09

Adolor Corporation announced a reduction in force of approximately 45 employees, or 28% of its workforce, as well as other cost saving initiatives intended to lower the Company's annualized net operating cash burn. The Company's primary focus going forward will continue to be on its first commercial product, ENTEREG, which was launched in mid-2008, and the advancement of its clinical programs. The Company is restructuring its discovery group to focus on late stage, preclinical compounds, with fewer resources dedicated to early-stage programs.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09

Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09

 See all of Regulatory Issues